glp-1 news today november 2025 ISPOR 2025: Exploring reasons for GLP-1 discontinuation GLP-1 trends 2025: real-world data,

Ozempic Role in Treating Diabetes and Weight Management Ozempic, a medication developed for diabetes treatment and weight management, is crucial in managing these conditions

Pharmacovigilance of triazole antifungal agents: analysis of the FDA adverse event reporting system (FAERS) database

The Obesity application segment is growing at the fastest CAGR during the forecast period as the addressable obesity patient population conservatively estimated at 800 million people globally with BMI above 30

There is, however, a class of medications known as GLP-1 agonists, which a medical professional may consider in the treatment of diagnosable diseases such as Type 2 diabetes

Billings, MD, MMSc The next steps involve launching Phase 3 clinical trials, which will study eloralintide in a much larger and more diverse group of participants to further examine eloralintides effectiveness and long-term safety, she added

And as demand continues to grow, what factors will determine whether patients can start and adhere to treatment long term